Hyperpolarized 129Xe MR Imaging of the Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Who is this study for? Adult patients with Interstitial Lung Disease
What treatments are being studied? Xenon-129 Gas
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI contrast will be the investigators focus - 1) imaging of the 129Xe ventilation distribution, 2) imaging the alveolar microstructure via the 129Xe apparent diffusion coefficient (ADC), and 3) imaging 129Xe that dissolves in the pulmonary blood and tissues upon inhalation. Such imaging of 129Xe gas transfer is expected to be uniquely sensitive to pathologies affecting gas exchange (fibrosis, emphysema, pulmonary hypertension) and provide new insights regarding the normal resting heterogeneity of pulmonary gas exchange.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Subject has no diagnosed pulmonary conditions

• Subject has not smoked in the previous 5 years.

• Smoking history, if any, is less than or equal to 5 pack-years.

• Subject has a diagnosis of pulmonary dysfunction made by a physician

• No acute worsening of pulmonary function in the past 30 days

Locations
United States
North Carolina
Duke University Medical Center
RECRUITING
Durham
Contact Information
Primary
Jennifer Korzekwinski
jennifer.korzekwinski@duke.edu
919-681-7362
Backup
Cody Blanton
cody.blanton@duke.edu
919-668-7575
Time Frame
Start Date: 2011-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 445
Sponsors
Leads: Bastiaan Driehuys

This content was sourced from clinicaltrials.gov